Radiopharmaceutical supply disruptions and the use of ^99mTc-hydroxymethylene diphosphonate as an alternative to ^99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement

Affiliations

• ¹ Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.
• ² Diagnóstico Maipú and Instituto Argentino de Diagnóstico y Tratamiento S.A, Buenos Aires, Argentina.
• ³ Division of Cardiology, Department of Medicine, Brown University Alpert Medical School, Providence, RI, USA.
• ⁴ Hartford HealthCare Heart & Vascular Institute, Hartford Hospital, Hartford, CT, USA.
• ⁵ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁶ Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, NY, USA.
• ⁷ Department of Cardiology, Université Paris-Est Créteil Val de Marne, Université Paris, Paris, France.
• ⁸ Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Centre, University Medical Center Groningen, Groningen, The Netherlands.
• ⁹ Seymour, Paul, and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, 622 West 168th Street PH 10-203, New York, NY, 10032, USA. ae2214@cumc.columbia.edu.
• ¹⁰ Department of Radiology, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, NY, USA. ae2214@cumc.columbia.edu.